Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Stomach Neoplasms 19Colorectal Neoplasms 16Esophageal Neoplasms 13Barrett Esophagus 8Colonic Neoplasms 7Rectal Neoplasms 6Gastrointestinal Neoplasms 6Colonic Polyps 6Neoplasms 3Duodenal Neoplasms 3Adenoma, Villous 3Adenocarcinoma Of Esophagus 3Precancerous Conditions 2Lung Neoplasms 2Hemorrhage 2Gastric GIST 2Esophageal Squamous Cell Carcinoma 2Carcinoma, Non-Small-Cell Lung 2Adenoma 2Tobacco Use Disorder 1Submucosal Tumor of Stomach 1Small Size Gastrointestinal Stromal Tumors 1Small Cell Lung Carcinoma 1Rectal Neuroendocrine Tumors 1Predictive Cancer Model 1Polyps 1Polyposis, Gastric 1Pituitary Neoplasms 1Personal Satisfaction 1Pathological Conditions, Anatomical 1

Interventions

dostarlimab 2Radiotherapy 2Oxaliplatin 2sintilimab 1irinotecan sucrosofate 1XELOX 1Neoadjuvant Therapy 1Immune Checkpoint Inhibitors 1Endoscopic Mucosal Resection 1Drug Therapy 1Capecitabine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Locally Advanced Rectal Cancer (LARC) × Endoscopic Mucosal Resection × Clear all
NCT06761287 2025-05-30

OPAL

Centre Hospitalier Universitaire Saint Pierre

Phase NA Recruiting
20 enrolled
Gastrointestinal

Locally Advanced Rectal Cancer (LARC)

Data powered by HemOnc (CC BY 4.0) Colophon âš¡